VahatiCor, Inc., a medtech company developing interventional therapies for coronary microvascular dysfunction (CMD), today announced the enrollment of the first United States patient in its SERRA-I ...
Fitgurú on MSN
Why heart disease may be a bigger threat than cancer for women in their 40s. Are you ignoring the warning signs?
Many women worry about breast cancer and other well-known health risks, but cardiologists warn that heart disease remains the ...
Doctors may soon be able to diagnose an elusive form of heart disease within seconds by using an AI model developed at University of Michigan, according to a recent study. Researchers trained the ...
Coronary microvascular dysfunction (CMD) was an important independent component of ischemic heart disease, though it often accompanied epicardial coronary artery disease, a prospective study showed.
A new review highlights the potential role of single nucleotide polymorphisms (SNPs) in improving the early diagnosis and targeted intervention of coronary microvascular dysfunction (CMD)—a condition ...
A study carried out at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) in Madrid, Spain provides crucial information about the effect of cardiometabolic risk factors and subclinical ...
Heart disease is the number-one killer of women, with over 60 million women (44%) in the U.S. living with some form of heart disease. There is one woman dying from heart disease every minute. The ...
ROCHESTER, Minn. — A study at Mayo Clinic suggests that an hourglass-shaped stent could improve blood flow and ease severe and reoccurring chest pain in people with microvascular disease. Of 30 ...
A viral X post about a 42-year-old woman whose heart disease was mistaken for anxiety has sparked fresh concerns about how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results